Marco Barbàra

Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

Vincenza Calvaruso, Giuseppe Cabibbo, Irene Cacciola et al. · Gastroenterology · 2018 · 362 citations

Medicine, Infectious Diseases, Internal Medicine +16

Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values

Salvatore Petta, Vincent Wai‐Sun Wong, Calogero Cammà et al. · Hepatology · 2016 · 212 citations

Medicine, Pathology, Radiology +17

Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study

Giuseppe Cabibbo, Salvatore Petta, Vincenza Calvaruso et al. · Alimentary Pharmacology & Therapeutics · 2017 · 147 citations · Full text

Medicine, Oncology, Pharmacology +15

Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib

Massimo Iavarone, Giuseppe Cabibbo, Marco Biolato et al. · Hepatology · 2015 · 131 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma

Giuseppe Cabibbo, Salvatore Petta, Marco Barbàra et al. · Journal of Hepatology · 2017 · 111 citations · Full text

Medicine, Infectious Diseases, Hepatology +14